MEN935
| Code | Size | Price |
|---|
| TAR-T24448-5mg | 5mg | £930.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
| TAR-T24448-50mg | 50mg | £1,821.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
| TAR-T24448-100mg | 100mg | £2,319.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
MEN935 is an antihypertensive agent. It is also a β-adrenoceptor blocker.
CAS:
75708-29-1
Formula:
C25H32ClN3O4
Molecular Weight:
474
Purity:
0.98
SMILES:
O.Cl.CC(C)(CCn1c2ccccc2[nH]c1=O)NCC(O)COc1cccc2ccccc12
References
1. Arrigoni J, Lambrecht JT. [Complications during and after third molar extraction]. Schweiz Monatsschr Zahnmed. 2004;114(12):1271-86. French, German. PubMed PMID: 15646673.
2. Wyszynski DF, Waterworth DM, Barter PJ, Cohen J, Kes?niemi YA, Mahley RW, McPherson R, Waeber G, Bersot TP, Sharma SS, Nolan V, Middleton LT, Sundseth SS, Farrer LA, Mooser V, Grundy SM. Relation between atherogenic dyslipidemia and the Adult Treatment Program-III definition of metabolic syndrome (Genetic Epidemiology of Metabolic Syndrome Project). Am J Cardiol. 2005 Jan 15;95(2):194-8. PubMed PMID: 15642551.
3. Eikelis N, Lambert G, Wiesner G, Kaye D, Schlaich M, Morris M, Hastings J, Socratous F, Esler M. Extra-adipocyte leptin release in human obesity and its relation to sympathoadrenal function. Am J Physiol Endocrinol Metab. 2004 May;286(5):E744-52. Epub 2004 Jan 13. PubMed PMID: 14722031.
4. Palluk R, Hoefke W, Gaida W, Mierau J, Bechtel WD. Interactions of MEN 935 (adimolol), a long acting beta- and alpha-adrenolytic antihypertensive agent, with postsynaptic alpha-adrenoceptors in different isolated blood vessels--influence of angiotensin II. Naunyn Schmiedebergs Arch Pharmacol. 1986 Jul;333(3):277-83. PubMed PMID: 3020439.